Alcista
$152.12
Precio del escenario
$116.620
+2.122 (+1.82%)Al cierre
Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.
Addus HomeCare Corp is currently a hold. The stock's current price is $114.33, with a forward P/E of 15.15, which suggests it is fairly valued compared to its earnings potential. However, the recent downgrade from BofA, which lowered the price target from $140 to $125, indicates caution due to slowing organic growth. Additionally, the RSI is at 60.49, suggesting it is nearing overbought territory, which could limit short-term upside. The main risk is the potential impact of Medicaid budget cuts, which could affect future earnings growth.
BofA
$125
2026-09-14
BofA
2026-09-14
Precio objetivo
$125
Barclays
$96
2026-07-08
Barclays
2026-07-08
Precio objetivo
$96
Barclays
$92
2026-05-15
Barclays
2026-05-15
Precio objetivo
$92
Citizens
$142
2026-05-06
Citizens
2026-05-06
Precio objetivo
$142
BofA
$140
2026-05-05
BofA
2026-05-05
Precio objetivo
$140
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Addus HomeCare to Release Q3 2026 Earnings on November 3

Addus HomeCare Executive Transition Announced

Addus HomeCare Q2 2026 Earnings Highlights

DaVita Inc. Q2 2026 Earnings Preview

Addus HomeCare Q2 Earnings Report Preview
Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Addus HomeCare Corp is currently a hold. The stock's current price is $114.33, with a forward P/E of 15.15, which suggests it is fairly valued compared to its earnings potential. However, the recent downgrade from BofA, which lowered the price target from $140 to $125, indicates caution due to slowing organic growth. Additionally, the RSI is at 60.49, suggesting it is nearing overbought territory, which could limit short-term upside. The main risk is the potential impact of Medicaid budget cuts, which could affect future earnings growth.
4 analysts cover ADUS: 3 rate it Buy, 1 Hold and 0 Sell. The average price target is 135.25.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.